Back
Esperion Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
ESPR
Esperion Therapeutics
Last Price:
$1.18
Seasonality Move:
-7.68%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Esperion Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.19 | Buy |
| 20-day SMA: | 1.11 | Buy |
| 50-day SMA: | 1.02 | Buy |
| 200-day SMA: | 1.69 | Sell |
| 8-day EMA: | 1.02 | Buy |
| 20-day EMA: | 0.65 | Buy |
| 50-day EMA: | 0.33 | Buy |
| 200-day EMA: | 0.09 | Buy |
Esperion Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.33 | Buy |
| Relative Strength Index (14 RSI): | 60.84 | Buy |
| Chaikin Money Flow: | 2308394 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.04 - 1.2) | Buy |
| Bollinger Bands (100): | (0.88 - 1.48) | Buy |
Esperion Therapeutics Technical Analysis
| Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Esperion Therapeutics Stock
Is Esperion Therapeutics Stock a Buy?
-
Esperion Therapeutics share price is 1.24 while ESPR 8-day simple moving average is 1.19, which is a Buy signal.
-
The stock price of ESPR is 1.24 while Esperion Therapeutics 20-day SMA is 1.11, which makes it a Buy.
-
Esperion Therapeutics 50-day simple moving average is 1.02 while ESPR share price is 1.24, making it a Buy technically.
-
ESPR stock price is 1.24 and Esperion Therapeutics 200-day simple moving average is 1.69, creating a Sell signal.
ESPR Technical Analysis vs Fundamental Analysis
Sell
44
Esperion Therapeutics (ESPR)
is a Sell
Is Esperion Therapeutics a Buy or a Sell?
-
Esperion Therapeutics stock is rated a SellThe current Esperion Therapeutics [ESPR] share price is $1.24. The Score for ESPR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Esperion Therapeutics Stock Info
Market Cap:
245.8M
Price in USD:
1.24
Share Volume:
3.6M
Esperion Therapeutics 52-Week Range
52-Week High:
3.94
52-Week Low:
0.69
Sell
44
Esperion Therapeutics (ESPR)
is a Sell
Esperion Therapeutics Share Price Forecast
-
What is the Esperion Therapeutics stock price today?The Esperion Therapeutics stock price is 1.24 USD today.
-
Will ESPR stock go up or go down?Esperion Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Esperion Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Esperion Therapeutics is overvalued.
Is Esperion Therapeutics Stock a Buy?
-
Esperion Therapeutics share price is 1.24 while ESPR 8-day exponential moving average is 1.02, which is a Buy signal.
-
The stock price of ESPR is 1.24 while Esperion Therapeutics 20-day EMA is 0.65, which makes it a Buy.
-
Esperion Therapeutics 50-day exponential moving average is 0.33 while ESPR share price is 1.24, making it a Buy technically.
-
ESPR stock price is 1.24 and Esperion Therapeutics 200-day simple moving average is 0.09, creating a Buy signal.
Fundamental Analysis of Esperion Therapeutics
Is Esperion Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.01 per share, and an increase next year of $0.14 per share.
Technical Analysis of Esperion Therapeutics
Should I short Esperion Therapeutics stock?
-
ESPR Moving Average Covergence Divergence (MACD) indicator is 0.33, suggesting Esperion Therapeutics is a Buy
-
Esperion Therapeutics Relative Strength Index (RSI) is 60.84, which suggest Esperion Therapeutics is overbought
-
The Bollinger Bands (25) for Esperion Therapeutics is (1.04 - 1.2), which suggest Esperion Therapeutics is a Buy
-
The Bollinger Bands (100) for Esperion Therapeutics is (0.88 - 1.48), which suggest Esperion Therapeutics is a Buy
* Esperion Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.